Skip to main content
Caplight Logo









Neubond

Neubond

Private
LondonHealthcare & Life Scienceshttps://neubond.co.uk

Last Round

Seed

Jun 24, 2026

Total Funding Raised

$2.97M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Neubond operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in June 2026.

Neubond is a therapeutic devices company that develops personalized home rehabilitation devices designed to empower stroke patients to regain mobility and independence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2G

Customer Profile

Hardware + Subscription, Government Contracts, Subscription SaaS, Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Neubond Comparables

Compare Neubond with similar companies based on industry and business-model similarity.

Neubond comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neurofenix
84%
GripAble
83%
Kandu, Inc.
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Neubond Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 24, 2026
GrantAug 19, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Neubond Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 25, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Aug 30, 2026

    Grew 27% QoQ, from 11 to 14 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Neubond Filings

Explore SEC and related filing metadata, where available.

Neubond filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Neubond's valuation, stock price, and market status.

Is Neubond a public or private company?

Neubond is a private company.

What is the current stock price of Neubond?

Neubond is a private company, so its shares have no public market price. Caplight tracks Neubond's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Neubond worth (valuation)?

Valuation information for Neubond is not publicly available.

Can I buy Neubond stock?

Neubond shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Neubond's last funding round?

Neubond's most recent funding round was Seed on June 24, 2026.

Who are the main investors in Neubond?

Key investors in Neubond include WASEDA University Ventures.

Will Neubond IPO soon?

No public IPO plans have been announced for Neubond.

How can I track Neubond secondary market activity?

Caplight tracks bids, offers, and trades in Neubond's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2024
Last FundingJun 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?